Molecure S.A. (WSE:MOC)

Molecure Statistics

Total Valuation

Molecure has a market cap or net worth of PLN 157.20 million. The enterprise value is 130.86 million.

Market Cap	157.20M
Enterprise Value	130.86M

Important Dates

The last earnings date was Tuesday, September 30, 2025.

Earnings Date	Sep 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Molecure has 20.60 million shares outstanding. The number of shares has increased by 21.20% in one year.

Current Share Class	20.60M
Shares Outstanding	20.60M
Shares Change (YoY)	+21.20%
Shares Change (QoQ)	+3.96%
Owned by Insiders (%)	0.90%
Owned by Institutions (%)	11.87%
Float	19.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.64
PB Ratio	1.66
P/TBV Ratio	4.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.15
EV / Sales	21.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.46

Financial Position

The company has a current ratio of 7.68, with a Debt / Equity ratio of 0.06.

Current Ratio	7.68
Quick Ratio	7.36
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.12
Interest Coverage	-530.91

Financial Efficiency

Return on equity (ROE) is -28.07% and return on invested capital (ROIC) is -17.05%.

Return on Equity (ROE)	-28.07%
Return on Assets (ROA)	-16.55%
Return on Invested Capital (ROIC)	-17.05%
Return on Capital Employed (ROCE)	-26.66%
Revenue Per Employee	66,632
Profits Per Employee	-276,266
Employee Count	102
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.42% in the last 52 weeks. The beta is 2.27, so Molecure's price volatility has been higher than the market average.

Beta (5Y)	2.27
52-Week Price Change	-28.42%
50-Day Moving Average	7.56
200-Day Moving Average	7.95
Relative Strength Index (RSI)	55.10
Average Volume (20 Days)	20,443

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Molecure had revenue of PLN 6.13 million and -25.42 million in losses. Loss per share was -1.15.

Revenue	6.13M
Gross Profit	3.30M
Operating Income	-26.35M
Pretax Income	-25.42M
Net Income	-25.42M
EBITDA	-26.67M
EBIT	-26.35M
Loss Per Share	-1.15

Balance Sheet

The company has 32.47 million in cash and 6.13 million in debt, giving a net cash position of 26.35 million or 1.28 per share.

Cash & Cash Equivalents	32.47M
Total Debt	6.13M
Net Cash	26.35M
Net Cash Per Share	1.28
Equity (Book Value)	94.70M
Book Value Per Share	4.60
Working Capital	29.86M

Cash Flow

In the last 12 months, operating cash flow was -53.07 million and capital expenditures -74,932, giving a free cash flow of -53.14 million.

Operating Cash Flow	-53.07M
Capital Expenditures	-74,932
Free Cash Flow	-53.14M
FCF Per Share	-2.58

Margins

Gross Margin	53.76%
Operating Margin	-429.91%
Pretax Margin	-414.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Molecure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.20%
Shareholder Yield	n/a
Earnings Yield	-16.17%
FCF Yield	-33.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Molecure has an Altman Z-Score of 11 and a Piotroski F-Score of 2.

Altman Z-Score	11
Piotroski F-Score	2